Search research articles
Contact Us
Filters
Showing results (21-30 of 32) with videos related to
Page
of 4
Sort By:
ACS Applied Materials & Interfaces
|
April 16, 2021
Restricted Channel Migration in 2D Multilayer ReS<sub>2</sub>
Chulmin Kim, Moonsoo Sung, Soo Yeon Kim, et al.
Journal of Virology
|
January 12, 2022
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
M Zeeshan Chaudhry, Kathrin Eschke, Markus Hoffmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 21, 2025
Longitudinal transformation of mitochondrial metabolism during neurogenesis
Donghoon Lim, Sewon Park, Jong Seung Lee, et al.
Plos One
|
August 2, 2021
Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies
Claudia Pommerenke, Ulfert Rand, Cord C Uphoff, et al.
Nanotechnology
|
December 10, 2020
Defect spectroscopy of sidewall interfaces in gate-all-around silicon nanosheet FET
Kookjin Lee, Yeonsu Kim, Hyebin Lee, et al.
Cellular & Molecular Immunology
|
January 7, 2022
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination
Yeonsu Kim, Xiaoyan Zheng, Kathrin Eschke, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2022
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Frontiers in Immunology
|
August 9, 2024
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Scientific Reports
|
November 18, 2022
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
Henning Jacobsen, Monika Strengert, Henrike Maaß, et al.
Nature Communications
|
March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
Federico Bertoglio, Doris Meier, Nora Langreder, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 32) with videos related to
Sort By:
Page
of 4
ACS Applied Materials & Interfaces
|
April 16, 2021
Restricted Channel Migration in 2D Multilayer ReS<sub>2</sub>
Chulmin Kim, Moonsoo Sung, Soo Yeon Kim, et al.
Journal of Virology
|
January 12, 2022
Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
M Zeeshan Chaudhry, Kathrin Eschke, Markus Hoffmann, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 21, 2025
Longitudinal transformation of mitochondrial metabolism during neurogenesis
Donghoon Lim, Sewon Park, Jong Seung Lee, et al.
Plos One
|
August 2, 2021
Identification of cell lines CL-14, CL-40 and CAL-51 as suitable models for SARS-CoV-2 infection studies
Claudia Pommerenke, Ulfert Rand, Cord C Uphoff, et al.
Nanotechnology
|
December 10, 2020
Defect spectroscopy of sidewall interfaces in gate-all-around silicon nanosheet FET
Kookjin Lee, Yeonsu Kim, Hyebin Lee, et al.
Cellular & Molecular Immunology
|
January 7, 2022
MCMV-based vaccine vectors expressing full-length viral proteins provide long-term humoral immune protection upon a single-shot vaccination
Yeonsu Kim, Xiaoyan Zheng, Kathrin Eschke, et al.
Biorxiv : the Preprint Server for Biology
|
December 9, 2022
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Frontiers in Immunology
|
August 9, 2024
A single-dose MCMV-based vaccine elicits long-lasting immune protection in mice against distinct SARS-CoV-2 variants
Kristin Metzdorf, Henning Jacobsen, Yeonsu Kim, et al.
Scientific Reports
|
November 18, 2022
Diminished neutralization responses towards SARS-CoV-2 Omicron VoC after mRNA or vector-based COVID-19 vaccinations
Henning Jacobsen, Monika Strengert, Henrike Maaß, et al.
Nature Communications
|
March 12, 2021
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface
Federico Bertoglio, Doris Meier, Nora Langreder, et al.
Page
of 4